1+ hour, 24+ min ago  (501+ words) Astra Zeneca has returned to China's CSPC Pharma to fill its R&D pipeline, reaching a new agreement to develop drugs for kidney diseases. Hong Kong-listed CSPC revealed the latest deal with AZ in a stock exchange filing (PDF), noting…...

3+ hour, 12+ min ago  (576+ words) Roche's chief medical officer, Levi Garraway. Roche has thrown down the gauntlet to Amgen and Bristol Myers Squibb with new phase 3 data for its experimental KRAS G12 C inhibitor, divarasib, which it says shows improved efficacy over their already approved therapies....

5+ hour, 29+ min ago  (585+ words) A federal judge in the US has sided with Amgen in a dispute over a price cap imposed by the state of Colorado on its blockbuster immunology drug Enbrel. In a move viewed as a test of states' ability to…...

1+ day, 1+ hour ago  (602+ words) In its second acquisition of the week, Ipsen will take control of Memo Therapeutics and a first-in-class drug for BK polyomavirus, which can cause serious complications in some transplant patients. The French pharma group will pay "200 million ($228 million) to shareholders…...

1+ day, 2+ hour ago  (638+ words) In reality, risk assessment is a structured scientific process that considers multiple factors together: how a substance behaves in a formulation, how it is used, how often exposure occurs, and how the body responds. Two compounds with similar hazard profiles…...

1+ day, 2+ hour ago  (1353+ words) Life sciences organisations are investing heavily in modern engagement platforms, but the results fall short." The issue usually isn't the technology itself. It's how organisations adjust their operating models, data, and day-to-day ways of working around it. After years of…...

1+ day, 2+ hour ago  (576+ words) Orca Bio has become a commercial-stage company with the FDA approval of Tregzi, a cell-based immunotherapy designed to prevent graft-versus-host disease (Gv HD) in people who need a bone marrow transplant. The regulatory T cell (Treg) therapy, formerly known as…...

1+ day, 4+ hour ago  (611+ words) As the US relaxes an export ban on Anthropic's advanced AI tools, the company formally launched Claude Science, an AI 'workbench' for researchers involved in drug discovery. Claude Science is the first product specifically designed by Anthropic for use by…...

1+ day, 6+ hour ago  (1076+ words) Life sciences companies are operating in a more complex commercial environment than ever before. Scientific innovation is moving quickly, regulatory expectations are rising, healthcare systems are under pressure, and companies must prove the value of their products earlier, more clearly…...

2+ day, 2+ hour ago  (513+ words) Intermediate magnification micrograph of mantle cell lymphoma of the terminal ileum. Patients with newly diagnosed mantle cell lymphoma (MCL) could avoid chemotherapy with a regimen based on Be One Medicines' Brukinsa and rituximab. That is the conclusion of the MANGROVE trial,…...